Patents by Inventor Yuiko Oya

Yuiko Oya has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PTH-CONTAINING THERAPEUTIC/PROPHYLACTIC AGENT FOR OSTEOPOROSIS, CHARACTERIZED IN THAT PTH IS ADMINISTERED ONCE A WEEK IN A UNIT DOSE OF 100 TO 200 UNITS
    Publication number: 20140357560
    Abstract: [Object] To provide a method of treating osteoporosis by PTH that has excellent safety and high efficacy. To provide a method for inhibiting/preventing bone fractures by PTH that has excellent safety. And to provide a drug to do this. [Means of Achievement] A drug containing PTH as the active ingredient, characterized in that a unit dose of PTH of 100 to 200 units is administered weekly in the above method.
    Type: Application
    Filed: July 14, 2014
    Publication date: December 4, 2014
    Inventors: Shinichiro SHIRAE, Yasuo NAKAMURA, Yuiko OYA, Yoshihide NOZAKI, Nobuyuki KOBAYASHI, Tatsuhiko KURODA, Hiroki KATO, Masahi SERADA, Kazuyoshi HORI
  • PTH-CONTAINING THERAPEUTIC/PROPHYLACTIC AGENT FOR OSTEOPOROSIS, CHARACTERIZED IN THAT PTH IS ADMINISTERED ONCE A WEEK IN A UNIT DOSE OF 100 TO 200 UNITS
    Publication number: 20140249084
    Abstract: [Object] To provide a method of treating osteoporosis by PTH that has excellent safety and high efficacy. To provide a method for inhibiting/preventing bone fractures by PTH that has excellent safety. And to provide a drug to do this. [Means of Achievement] A drug containing PTH as the active ingredient, characterized in that a unit dose of PTH of 100 to 200 units is administered weekly in the above method.
    Type: Application
    Filed: March 5, 2014
    Publication date: September 4, 2014
    Applicant: ASAHI KASEI PHARMA CORPORATION
    Inventors: Shinichiro SHIRAE, Yasuo NAKAMURA, Yuiko OYA, Yoshihide NOZAKI, Nobuyuki KOBAYASHI, Tatsuhiko KURODA, Hiroki KATO, Masashi SERADA, Kazuyoshi HORI
  • PTH-CONTAINING THERAPEUTIC/PROPHYLACTIC AGENT FOR OSTEOPOROSIS, CHARACTERIZED IN THAT PTH IS ADMINISTERED ONCE A WEEK IN A UNIT DOSE OF 100 TO 200 UNITS
    Publication number: 20120252729
    Abstract: A method of treating osteoporosis by PTH that has excellent safety and high efficacy is disclosed, along with a method for inhibiting/preventing bone fractures by PTH that has excellent safety, as well as providing a drug to do this. A drug containing PTH as the active ingredient is disclosed, characterized in that a unit dose of PTH of 100 to 200 units is administered weekly in the above method.
    Type: Application
    Filed: September 8, 2010
    Publication date: October 4, 2012
    Applicant: ASAHI KASEI PHARMA CORPORATION
    Inventors: Shinichiro Shirae, Yasuo Nakamura, Yuiko Oya, Yoshihide Nozaki, Nobuyuki Kobayashi, Tatsuhiko Kuroda, Hiroki Kato, Masashi Serada, Kazuyoshi Hori